Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118234553 | 11823455 | 3 | F | 20160825 | 20160826 | 20151210 | 20160831 | EXP | PHHY2015CO159114 | NOVARTIS | 65.19 | YR | F | Y | 55.00000 | KG | 20160831 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118234553 | 11823455 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, BID | 22334 | 5 | MG | TABLET | BID | ||||||
| 118234553 | 11823455 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, BID | 22334 | 5 | MG | TABLET | BID | ||||||
| 118234553 | 11823455 | 3 | C | EXEMESTANE. | EXEMESTANE | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 118234553 | 11823455 | 4 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | UNK UNK, BID | U | N | 0 | BID | |||||||
| 118234553 | 11823455 | 5 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK UNK, PRN (ACCORDING TO PAIN) | U | 0 | |||||||||
| 118234553 | 11823455 | 6 | C | MORPHINE | MORPHINE | 1 | Unknown | 17 DRP, QID (3 OR 4 TIMES A DAY 12 DROPS DURIGN THE DAY AND 15 DROPS AT NIGHT) | U | 0 | 17 | GTT | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118234553 | 11823455 | 1 | Renal cancer |
| 118234553 | 11823455 | 2 | Breast cancer metastatic |
| 118234553 | 11823455 | 3 | Product used for unknown indication |
| 118234553 | 11823455 | 4 | Product used for unknown indication |
| 118234553 | 11823455 | 5 | Product used for unknown indication |
| 118234553 | 11823455 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118234553 | 11823455 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118234553 | 11823455 | Asphyxia | |
| 118234553 | 11823455 | Blood glucose decreased | |
| 118234553 | 11823455 | Blood pressure decreased | |
| 118234553 | 11823455 | Feeling of despair | |
| 118234553 | 11823455 | General physical health deterioration | |
| 118234553 | 11823455 | Impaired self-care | |
| 118234553 | 11823455 | Lack of spontaneous speech | |
| 118234553 | 11823455 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118234553 | 11823455 | 1 | 20150904 | 20151117 | 0 | |
| 118234553 | 11823455 | 2 | 20160823 | 0 |